1988
DOI: 10.1007/bf00390480
|View full text |Cite
|
Sign up to set email alerts
|

Tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland of fluorinated derivatives of benzo[a]pyrene and 3-methylcholanthrene

Abstract: Comparative studies of tumor-initiating activity in mouse skin and carcinogenicity in rat mammary gland were conducted with benzo[a]pyrene (BP) and 3-methylcholanthrene (MC) derivatives. SENCAR mice were initiated with BP, 6-fluorobenzo[a]pyrene (6-FBP), 6-methylBP, 7-FBP, 8-FBP, 9-FBP, 10-FBP, or 10-azaBP and promoted with tetradecanoyl phorbol acetate. The same compounds plus BP 7,8-dihydrodiol were tested by intramammillary injection in female Sprague-Dawley rats. Tumor-initiating activity in mice and/or ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
26
0

Year Published

1988
1988
2016
2016

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(26 citation statements)
references
References 19 publications
0
26
0
Order By: Relevance
“…For example, 6-fluorobenzo[ c ]phenanthrene (6-F-B c Ph) showed increased tumorigenicity as compared to benzo[ c ]phenanthrene (B c Ph), 8 whereas 6-fluorobenzo[ a ]pyrene (6-F-B a P) showed decreased tumorigenicity as compared to benzo[ a ]pyrene (B a P). 9 In the latter case this is attributed to fluorine-atom-induced conformational change in the metabolite. 9b Studies on the effect molecular distortion of PAHs can have on metabolic activation and DNA binding have been conducted using 1,4-difluorobenzo[ c ]phenanthrene as a model compound.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, 6-fluorobenzo[ c ]phenanthrene (6-F-B c Ph) showed increased tumorigenicity as compared to benzo[ c ]phenanthrene (B c Ph), 8 whereas 6-fluorobenzo[ a ]pyrene (6-F-B a P) showed decreased tumorigenicity as compared to benzo[ a ]pyrene (B a P). 9 In the latter case this is attributed to fluorine-atom-induced conformational change in the metabolite. 9b Studies on the effect molecular distortion of PAHs can have on metabolic activation and DNA binding have been conducted using 1,4-difluorobenzo[ c ]phenanthrene as a model compound.…”
Section: Introductionmentioning
confidence: 99%
“…9 In the latter case this is attributed to fluorine-atom-induced conformational change in the metabolite. 9b Studies on the effect molecular distortion of PAHs can have on metabolic activation and DNA binding have been conducted using 1,4-difluorobenzo[ c ]phenanthrene as a model compound. 10 In order to better understand the structure-activity relationships on molecular-genetic level, availability of sufficient quantities of regiospecifically fluorinated PAHs is critical.…”
Section: Introductionmentioning
confidence: 99%
“…6-Fluoro-BP is a weaker carcinogen than BP (26,39). The profile of stable adducts of 6-fluoro-BP formed in vitro after activation by rat liver microsomes resembles that of BP (23), but its depurinating adducts have not been analyzed.…”
mentioning
confidence: 99%
“…In contrast, 6-methyl BP (6-CH 3 BP) ( Fig. 1) is mutagenic [5,6], teratogenic [7] and carcinogenic, although it is a weaker carcinogen than BP [8][9][10][11]. In addition, 6-CH 3 BP is produced by bioalkylation of BP with rat liver cytosol and S-adenosyl methionine, and therefore, has been suggested as a possible contributor in BP carcinogenesis [12,13].…”
Section: Introductionmentioning
confidence: 99%